Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. North America and Europe Stroke Diagnostics Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. North America and Europe Stroke Diagnostics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. North America and Europe Stroke Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. North America and Europe Stroke Diagnostics Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
4.3. Magnetic Resonance Imaging (MRI)
4.3.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Computed Tomography Scan (CT Scan) Software
4.4.1. Computed Tomography Scan (CT Scan) Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.5. Carotid Ultrasound Services
4.5.1. Carotid Ultrasound Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6. Cerebral Angiography Services
4.6.1. Cerebral Angiography Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7. Nuclear Imaging Services
4.7.1. Nuclear Imaging Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. North America and Europe Stroke Diagnostics Market: Regional Estimates & Trend Analysis
5.1. North America and Europe Market Share, By Region, 2023 & 2030 (USD Billion)
5.2. North America
5.2.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.2.2. U.S.
5.2.2.1. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.2.3. Canada
5.2.3.1. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.2.4. Mexico
5.2.4.1. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3. Europe
5.3.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.2. U.K.
5.3.2.1. U.K. Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.3. Germany
5.3.3.1. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.4. France
5.3.4.1. France Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.5. Italy
5.3.5.1. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.6. Spain
5.3.6.1. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.7. Denmark
5.3.7.1. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.8. Sweden
5.3.8.1. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.9. Norway
5.3.9.1. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Categorization
6.3. Company Heat Map Analysis
6.4. Company Profiles
6.4.1. Siemens Healthineers AG
6.4.1.1. Participant’s Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Recent Developments/ Strategic Initiatives
6.4.2. Cordis.
6.4.2.1. Participant’s Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Recent Developments/ Strategic Initiatives
6.4.3. Boston Scientific Corporation
6.4.3.1. Participant’s Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Recent Developments/ Strategic Initiatives
6.4.4. GE HealthCare
6.4.4.1. Participant’s Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Recent Developments/ Strategic Initiatives
6.4.5. Koninklijke Philips N.V.
6.4.5.1. Participant’s Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Recent Developments/ Strategic Initiatives
6.4.6. TOSHIBA CORPORATION
6.4.6.1. Participant’s Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Recent Developments/ Strategic Initiatives
6.4.7. Hitachi High-Tech Corporation
6.4.7.1. Participant’s Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Recent Developments/ Strategic Initiatives
6.4.8. Neusoft Corporation
6.4.8.1. Participant’s Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Recent Developments/ Strategic Initiatives